Treatment Update – Silkis Ointment

Galderma, the manufacturer of Silkis Ointment (Calcitriol), have today confirmed that the treatment is discontinued,

We have received the following statement from Galderma:

"Galderma has taken the decision to discontinue Silkis®. As such, we encourage you to consider alternative therapeutic options for your patients. Silkis® has been out of stock due to manufacturing/technical difficulties encountered, for certain batches, in meeting the finished product release specification for viscosity. Batches circulating in the UK supply chain continue to meet specification. A limited quantity of new stock – that also meets specification – will be available from around early August 2026. However, no further Silkis® will be available after this small amount of new stock has run out."

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01923 208 950, or by email at info.uk@galderma.com.

This is correct at the time of writing. (July 2026).

You can find more information about currently unavailable treatments here.